Amicus Therapeutics (FOLD) Profit After Tax: 2009-2025
Historic Profit After Tax for Amicus Therapeutics (FOLD) over the last 16 years, with Sep 2025 value amounting to $17.3 million.
- Amicus Therapeutics' Profit After Tax rose 357.19% to $17.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.1 million, marking a year-over-year increase of 86.57%. This contributed to the annual value of -$56.1 million for FY2024, which is 62.99% up from last year.
- According to the latest figures from Q3 2025, Amicus Therapeutics' Profit After Tax is $17.3 million, which was up 170.87% from -$24.4 million recorded in Q2 2025.
- Amicus Therapeutics' Profit After Tax's 5-year high stood at $17.3 million during Q3 2025, with a 5-year trough of -$85.3 million in Q1 2022.
- Its 3-year average for Profit After Tax is -$21.5 million, with a median of -$21.7 million in 2025.
- Data for Amicus Therapeutics' Profit After Tax shows a peak YoY increase of 357.19% (in 2025) and a maximum YoY decrease of 55.57% (in 2025) over the last 5 years.
- Amicus Therapeutics' Profit After Tax (Quarterly) stood at -$83.3 million in 2021, then soared by 32.92% to -$55.9 million in 2022, then skyrocketed by 39.42% to -$33.8 million in 2023, then spiked by 143.55% to $14.7 million in 2024, then surged by 357.19% to $17.3 million in 2025.
- Its last three reported values are $17.3 million in Q3 2025, -$24.4 million for Q2 2025, and -$21.7 million during Q1 2025.